2021-05-04, 13:35
Human organ chips enable rapid drug repurposing for COVID-19
A Wyss Institute-led collaboration has used the institute’s organ-on-a-chip technology to identify the antimalarial drug amodiaquine as a potent inhibitor of infection with SARS-CoV-2, the virus that causes COVID-19.
https://news.harvard.edu/gazette/story/2...edium=Feed&utm_source=Syndication
A Wyss Institute-led collaboration has used the institute’s organ-on-a-chip technology to identify the antimalarial drug amodiaquine as a potent inhibitor of infection with SARS-CoV-2, the virus that causes COVID-19.
https://news.harvard.edu/gazette/story/2...edium=Feed&utm_source=Syndication